Table 3.
Biopharmaceutical category | Reported sales value ($ billion) |
---|---|
Originatora recombinant proteins: mAbs | 217.3 |
Originator recombinant proteins: non-mAbs | 53.6 |
Covid vaccines (Comirnaty and Spikevax) | 54.5 |
Biosimilars | 11.1 |
Nucleic acid and engineered cell based | 6.8 |
Total value | 343.3 |
aOriginator’ signifies non-biosimilar.